BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25916346)

  • 1. A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements.
    Franchignoni F; Mandrioli J; Giordano A; Ferro S;
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):331-7. PubMed ID: 25916346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis.
    Franchignoni F; Mora G; Giordano A; Volanti P; Chiò A
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1340-5. PubMed ID: 23516308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.
    Mehdipour A; Teshler L; Dal Bello-Haas V; Richardson J; Beauchamp M; Turnbull J; Chum M; Johnston W; O'Connell C; Luth W; Kuspinar A
    Phys Ther; 2023 Nov; 103(11):. PubMed ID: 37581600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
    Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
    Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
    JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.
    Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Malaspina A; Mills R; Tennant A
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):400-409. PubMed ID: 38426231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
    Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
    Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model.
    Bakker LA; Schröder CD; van Es MA; Westers P; Visser-Meily JMA; van den Berg LH
    J Neurol; 2017 Jul; 264(7):1413-1420. PubMed ID: 28608303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database.
    Bacci ED; Staniewska D; Coyne KS; Boyer S; White LA; Zach N; Cedarbaum JM;
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(3-4):157-67. PubMed ID: 26473473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
    Park Y; Park J; Kim Y; Baek H; Kim SH
    Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale.
    Sun C; Fournier CN; Ye S; Zhang N; Ma Y; Fan D
    Eur J Neurol; 2021 Jun; 28(6):1876-1883. PubMed ID: 33686758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring function in advanced ALS: validation of ALSFRS-EX extension items.
    Wicks P; Massagli MP; Wolf C; Heywood J
    Eur J Neurol; 2009 Mar; 16(3):353-9. PubMed ID: 19364363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).
    Cedarbaum JM; Stambler N; Malta E; Fuller C; Hilt D; Thurmond B; Nakanishi A
    J Neurol Sci; 1999 Oct; 169(1-2):13-21. PubMed ID: 10540002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALS.
    de Jongh AD; van Eijk RPA; Bakker LA; Bunte TM; Beelen A; van der Meijden C; van Es MA; Visser-Meily JMA; Kruitwagen ET; Veldink JH; van den Berg LH
    Neurology; 2023 Aug; 101(6):e602-e612. PubMed ID: 37311649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing upper limb function with ALSFRS-R in amyotrophic lateral sclerosis patients.
    Pinto S; Gromicho M; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):445-448. PubMed ID: 31032642
    [No Abstract]   [Full Text] [Related]  

  • 19. A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.
    Daghlas I; Lever TE; Leary E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):206-211. PubMed ID: 29260911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study.
    Mandrioli J; Biguzzi S; Guidi C; Venturini E; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Chierici E; Santangelo M; Granieri E; Mussuto V; Borghi A; Rinaldi R; Fini N; Georgoulopoulou E; De Pasqua S; Vinceti M; Bonvicini F; ; Ferro S; D'Alessandro R
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):262-8. PubMed ID: 24863640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.